Assembly Biosciences Executive Compensation Details

Ticker: ASMB · Form: DEF 14A · Filed: 2025-04-23T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, equity-awards, sec-filing

TL;DR

Assembly Bio exec comp details out: check out Nicole White, Bill Delaney, Jason Okazaki's equity awards for 2024.

AI Summary

Assembly Biosciences, Inc. filed a DEF 14A on April 23, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to key personnel such as Nicole S. White, William E. Delaney IV, and Jason A. Okazaki, with specific dates of grant and valuation data for outstanding and unvested awards.

Why It Matters

This filing provides transparency into how Assembly Biosciences compensates its top executives, which can influence investor decisions and perceptions of company management.

Risk Assessment

Risk Level: low — This is a routine filing related to executive compensation and does not inherently present new financial risks.

Key Players & Entities

FAQ

What was the fiscal year end for Assembly Biosciences, Inc. covered by this filing?

The fiscal year end covered by this filing was December 31, 2024.

When was this DEF 14A filing submitted to the SEC?

This DEF 14A filing was submitted on April 23, 2025.

Who are some of the key individuals whose compensation is detailed in this filing?

Key individuals mentioned include Nicole S. White, William E. Delaney IV, and Jason A. Okazaki.

What type of compensation information is being disclosed?

The filing details information related to equity awards, including year-end fair value of awards granted, outstanding and unvested awards, and changes in fair value.

What is the SIC code for Assembly Biosciences, Inc.?

The Standard Industrial Classification (SIC) code for Assembly Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0000950170-25-057353.txt : 20250423 0000950170-25-057353.hdr.sgml : 20250423 20250423161015 ACCESSION NUMBER: 0000950170-25-057353 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250605 FILED AS OF DATE: 20250423 DATE AS OF CHANGE: 20250423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001426800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35005 FILM NUMBER: 25861541 BUSINESS ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (833) 409-4583 MAIL ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC DATE OF NAME CHANGE: 20080211 DEF 14A 1 asmb-20250422.htm DEF 14A DEF 14A 0001426800 false DEF 14A 0001426800 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-01-01 2024-12-31 0001426800 ecd:NonPeoNeoMember ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember 2024-01-01 2024-12-31 0001426800 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2022-01-01 2022-12-31 0001426800 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2023-01-01 2023-12-31 0001426800 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2024-01-01 2024-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2024-01-01 2024-12-31 0001426800 asmb:NicoleSWhiteMember 2024-03-29 0001426800 asmb:WilliamEDelaneyIVMember 2024-03-29 0001426800 asmb:JasonAOkazakiMember 2024-03-29 0001426800 ecd:NonPeoNeoMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember 2022-01-01 2022-12-31 0001426800 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember 2022-01-01 2022-12-31 0001426800 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2023-01-01 2023-12-31 0001426800 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember 2022-01-01 2022-12-31 0001426800 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2022-01-01 2022-12-31 0001426800 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2022-01-01 2022-12-31 0001426800 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2022-01-01 2022-12-31 0001426800 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember 2023-01-01 2023-12-31 0001426800 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-31 0001426800 2024-01-01 2024-12-31 0001426800 2022-01-01 2022-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember 2023-01-01 2023-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember 2024-01-01 2024-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2024-01-01 2024-12-31 0001426800 ecd:NonPeoNeoMember ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember 2022-01-01 2022-12-31 0001426800 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-31 utr:Rate xbrli:shares iso4217:USD iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND E

View on Read The Filing